Cargando…

Cathepsin B cleavage of the trypsinogen activation peptide

BACKGROUND: Cathepsin B is thought to play a central role in intrapancreatic trypsinogen activation and the onset of pancreatitis. A recent investigation of the cathepsin B mediated activability of wildtype trypsinogen and their mutations N29I, N29T and R122H, which are associated to hereditary panc...

Descripción completa

Detalles Bibliográficos
Autores principales: Teich, Niels, Bödeker, Hans, Keim, Volker
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117221/
https://www.ncbi.nlm.nih.gov/pubmed/12102727
http://dx.doi.org/10.1186/1471-230X-2-16
_version_ 1782120277804580864
author Teich, Niels
Bödeker, Hans
Keim, Volker
author_facet Teich, Niels
Bödeker, Hans
Keim, Volker
author_sort Teich, Niels
collection PubMed
description BACKGROUND: Cathepsin B is thought to play a central role in intrapancreatic trypsinogen activation and the onset of pancreatitis. A recent investigation of the cathepsin B mediated activability of wildtype trypsinogen and their mutations N29I, N29T and R122H, which are associated to hereditary pancreatitis, revealed no differences. This action seems to be restricted to the K23-I24 peptide bond, which is the trypsinogen activation bond. Here we investigated the influence of the mutations D22G and K23R of the trypsinogen activation peptide on the cleavability by cathepsin B. METHODS: To investigate the functional impact of the TAP mutations on cathepsin B mediated cleavage of the trypsinogen activating K23-I24 bond, the corresponding peptides pWT, APFDDDDKIVGG; pD22G, APFDDDGKIVGG; and pK23R, APFDDDDRIVGG were digested with cathepsin B for 30 min at pH 3.8 and 5.0, and the fragments were analysed by high-performance liquid chromatography. RESULTS: Without cathepsin B, less than 1 % of the peptides were hydrolysed. After a 30-minute digestion with cathepsin B at pH 5, 96% of pWT, 48% of pK23R, but only 2.4% of pD22G were hydrolysed. At pH 3.8, the cathepsin B cleavage of pWT and pK23R was less than at pH 5, whereas the cleavage of pD22G was completely inhibited CONCLUSIONS: Cathepsin B mediated trypsinogen activation seems not to be a crucial pathogenic step in hereditary pancreatitis patients with the trypsinogen mutations D22G and K23R.
format Text
id pubmed-117221
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1172212002-07-18 Cathepsin B cleavage of the trypsinogen activation peptide Teich, Niels Bödeker, Hans Keim, Volker BMC Gastroenterol Research Article BACKGROUND: Cathepsin B is thought to play a central role in intrapancreatic trypsinogen activation and the onset of pancreatitis. A recent investigation of the cathepsin B mediated activability of wildtype trypsinogen and their mutations N29I, N29T and R122H, which are associated to hereditary pancreatitis, revealed no differences. This action seems to be restricted to the K23-I24 peptide bond, which is the trypsinogen activation bond. Here we investigated the influence of the mutations D22G and K23R of the trypsinogen activation peptide on the cleavability by cathepsin B. METHODS: To investigate the functional impact of the TAP mutations on cathepsin B mediated cleavage of the trypsinogen activating K23-I24 bond, the corresponding peptides pWT, APFDDDDKIVGG; pD22G, APFDDDGKIVGG; and pK23R, APFDDDDRIVGG were digested with cathepsin B for 30 min at pH 3.8 and 5.0, and the fragments were analysed by high-performance liquid chromatography. RESULTS: Without cathepsin B, less than 1 % of the peptides were hydrolysed. After a 30-minute digestion with cathepsin B at pH 5, 96% of pWT, 48% of pK23R, but only 2.4% of pD22G were hydrolysed. At pH 3.8, the cathepsin B cleavage of pWT and pK23R was less than at pH 5, whereas the cleavage of pD22G was completely inhibited CONCLUSIONS: Cathepsin B mediated trypsinogen activation seems not to be a crucial pathogenic step in hereditary pancreatitis patients with the trypsinogen mutations D22G and K23R. BioMed Central 2002-06-27 /pmc/articles/PMC117221/ /pubmed/12102727 http://dx.doi.org/10.1186/1471-230X-2-16 Text en Copyright © 2002 Teich et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Teich, Niels
Bödeker, Hans
Keim, Volker
Cathepsin B cleavage of the trypsinogen activation peptide
title Cathepsin B cleavage of the trypsinogen activation peptide
title_full Cathepsin B cleavage of the trypsinogen activation peptide
title_fullStr Cathepsin B cleavage of the trypsinogen activation peptide
title_full_unstemmed Cathepsin B cleavage of the trypsinogen activation peptide
title_short Cathepsin B cleavage of the trypsinogen activation peptide
title_sort cathepsin b cleavage of the trypsinogen activation peptide
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117221/
https://www.ncbi.nlm.nih.gov/pubmed/12102727
http://dx.doi.org/10.1186/1471-230X-2-16
work_keys_str_mv AT teichniels cathepsinbcleavageofthetrypsinogenactivationpeptide
AT bodekerhans cathepsinbcleavageofthetrypsinogenactivationpeptide
AT keimvolker cathepsinbcleavageofthetrypsinogenactivationpeptide